Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patients

• Published in: Rheumatology (Oxford, England) England), 2014-08, Vol.53 (8), p.1504-1512
• Main Authors: Chiewchengchol, Direkrit, Murphy, Ruth, Morgan, Thomas, Edwards, Steven W, Leone, Valentina, Friswell, Mark, Pilkington, Clarissa, Tullus, Kjell, Rangaraj, Satyapal, McDonagh, Janet E, Gardner-Medwin, Janet, Wilkinson, Nick, Riley, Phil, Tizard, Jane, Armon, Kate, Sinha, Manish D, Ioannou, Yiannis, Mann, Rebecca, Bailey, Kathryn, Davidson, Joyce, Baildam, Eileen M, Pain, Clare E, Cleary, Gavin, McCann, Liza J, Beresford, Michael W
• Format: Article
• Language: English
• Subjects: Adolescent; Child; Female; Humans; Lupus Erythematosus, Systemic - complications; Lupus Erythematosus, Systemic - pathology; Male; Severity of Illness Index; Skin - pathology; Skin Diseases - complications; Skin Diseases - pathology
• ISSN: 1462-0324; 1462-0332
• DOI: 10.1093/rheumatology/keu137

To determine whether mucocutaneous manifestations are associated with major organ involvement in a UK national cohort of juvenile-onset SLE (JSLE) patients. JSLE patients (n = 241) from 15 different centres whose diagnosis fulfilled four or more of the ACR criteria were divided into two groups: those with at least one ACR mucocutaneous criterion (ACR skin feature positive) and those without (ACR skin feature negative) at diagnosis. The relative frequency of skin involvement was described by the paediatric adaptation of the 2004 British Isles Lupus Assessment Group (pBILAG-2004) index. One hundred and seventy-nine patients (74%) had ACR-defined skin involvement with no significant demographic differences compared with those without. ACR skin feature negative patients showed greater haematological (84% vs 67%), renal (43% vs 26%) (P < 0.05) and neurological (16% vs 4%) involvement (P = 0.001). Forty-two per cent of ACR skin feature negative patients had skin involvement using pBILAG-2004, which included maculopapular rash (17%), non-scaring alopecia (15%), cutaneous vasculitis (12%) and RP (12%). ACR skin feature negative patients with moderate to severe skin involvement by pBILAG-2004 showed greater renal and haematological involvement at diagnosis and over the follow-up period (P < 0.05). Higher immunosuppressive drug use in the skin feature negative group was demonstrated. Patients who fulfil the ACR criteria but without any of the mucocutaneous criteria at diagnosis have an increased risk of major organ involvement. The pBILAG-2004 index has shown that other skin lesions may go undetected using the ACR criteria alone, and these lesions show a strong correlation with disease severity and major organ involvement.